Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Intensity-modulated Radiation Therapy”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableLooking for participantsNCT06630793
What this trial is testing

IMRT Versus IMPT With Concurrent Chemotherapy for Locally Advanced Anal Canal Cancer

Who this might be right for
Malignant Neoplasm of Anal Canal
Tata Memorial Centre 108
Testing effectiveness (Phase 2)Study completedNCT03067610
What this trial is testing

Involved Field Elective Volume De-Intensification Radiation Therapy for Head and Neck Cancer

Who this might be right for
Head and Neck CancerCarcinoma, Squamous CellNeoplasms, Oral+1 more
University of Texas Southwestern Medical Center 72
Large-scale testing (Phase 3)Study completedNCT03387774
What this trial is testing

Efficacy of Ulinastatin for Reducing Radiation-Induced Oral Mucositis in Nasopharyngeal Carcinoma Patients

Who this might be right for
Oral Mucositis (Ulcerative) Due to Radiation
Sun Yat-sen University 179
Testing effectiveness (Phase 2)Study completedNCT00188877
What this trial is testing

Intensity Modulated Radiation Therapy for Head and Neck Cancer

Who this might be right for
Nasopharyngeal Neoplasms
University Health Network, Toronto 44
Testing effectiveness (Phase 2)UnknownNCT02610556
What this trial is testing

Concurrent Docetaxel Plus Cisplatin or Cisplatin Alone With IMRT in High Risk Nasopharyngeal Carcinoma

Who this might be right for
Nasopharyngeal Carcinoma
Sun Yat-sen University 130
Large-scale testing (Phase 3)Looking for participantsNCT04448522
What this trial is testing

Reduced vs Conventional Dosage Intensity-modulated Radiotherapy for Chemotherapy-sensitive Stage II-III Nasopharyngeal Carcinoma

Who this might be right for
Nasopharyngeal CarcinomaRadiotherapyChemotherapy
Sun Yat-sen University 508
Early research (Phase 1)Study completedNCT01134146
What this trial is testing

Radical Pleurectomy/Decortication (PD) and Intensity Modulated Radiotherapy (IMRT)

Who this might be right for
Lung CancerMesothelioma
M.D. Anderson Cancer Center 11
Testing effectiveness (Phase 2)Study completedNCT00551525
What this trial is testing

Samarium Sm 153 Lexidronam Pentasodium and 3-Dimensional Conformal Radiation Therapy or Intensity-Modulated Radiation Therapy in Treating Patients With Rising Prostate-Specific Antigen Levels After Radical Prostatectomy for Prostate Cancer

Who this might be right for
Prostate Cancer
Radiation Therapy Oncology Group 67
Not applicableUnknownNCT00392535
What this trial is testing

Intensity-Modulated Radiation Therapy in Treating Patients With Localized Prostate Cancer

Who this might be right for
Prostate Cancer
Institute of Cancer Research, United Kingdom 3,216
Not applicableUnknownNCT02627807
What this trial is testing

Clinical Target Volume Based on Disease Extension Risk Atlas and Computer-aided Delineation in Nasopharyngeal Carcinoma

Who this might be right for
Nasopharyngeal Neoplasms
Sun Yat-sen University 386
Testing effectiveness (Phase 2)Study completedNCT01166191
What this trial is testing

Concurrent Chemo-radiotherapy With Intensity-Modulated Radiation Therapy (IMRT) for Limited Disease Small Cell Lung Cancer (LD-SCLC)

Who this might be right for
Stage I-III Small Cell Lung Cancer
Maastricht Radiation Oncology 60
Testing effectiveness (Phase 2)WithdrawnNCT00257335
What this trial is testing

Intensity-Modulated Radiotherapy for Recurrent Head and Neck Cancer

Who this might be right for
Carcinoma of the Head and Neck
Nilam Ramsinghani
Testing effectiveness (Phase 2)UnknownNCT00938418
What this trial is testing

Hypofractionated Intensity Modulated Chemoradiotherapy to Treat Locally Advanced Non-Small Cell Lung Cancer

Who this might be right for
Stage III Non-Small Cell Lung Cancer
National University Hospital, Singapore 43
Large-scale testing (Phase 3)Active Not RecruitingNCT02460887
What this trial is testing

The Role of Induction Gemcitabine and Cisplatin in Locoregionally Advanced Nasopharyngeal Carcinoma in the Era of IMRT

Who this might be right for
Nasopharyngeal Carcinoma
Sun Yat-sen University 236
Early research (Phase 1)Study completedNCT00911118
What this trial is testing

Dose Escalation Study Using Ultra-Hypofractionated, Image-Guided, Intensity-Modulated Radiotherapy in Prostate Cancer

Who this might be right for
Prostate CancerAdenocarcinoma
Memorial Sloan Kettering Cancer Center 120
Early research (Phase 1)Ended earlyNCT03066154
What this trial is testing

Oral Docetaxel (ModraDoc/r) in Combination With Hormonal Treatment and Radiation Therapy in High-risk Prostate Cancer

Who this might be right for
Prostatic Neoplasms
The Netherlands Cancer Institute 24
Early research (Phase 1)Ended earlyNCT00692380
What this trial is testing

Gated Intensity Modulated Radiation Therapy and Concurrent Chemotherapy for Inoperable NSCLC

Who this might be right for
Non-small Cell Lung Cancer
Virginia Commonwealth University 28
Early research (Phase 1)UnknownNCT00527631
What this trial is testing

Adjuvant Whole Abdominal Intensity Modulated Radiotherapy (IMRT) for High Risk Stage FIGO III Patients With Ovarian Cancer

Who this might be right for
Ovarian Cancer
Heidelberg University 8
Large-scale testing (Phase 3)Study completedNCT02633202
What this trial is testing

Concurrent Chemotherapy for the Intermediate Risk Nasopharyngeal Carcinoma In Intensity-modulated Radiotherapy Era

Who this might be right for
Nasopharyngeal Carcinoma
Sun Yat-sen University 338
Testing effectiveness (Phase 2)Study completedNCT02772588
What this trial is testing

AASUR in High Risk Prostate Cancer

Who this might be right for
Prostate Cancer
Memorial Sloan Kettering Cancer Center 64
Next Page